Autoimmune hepatitis type 2 following anti-papillomavirus vaccination in a 11-year-old girl

Vaccine

Volumn 29, Issue 29-30, 2011, Pages 4654-4656

  Corte, Claudia Della ^a   Carlucci, Antonio ^b   Francalanci, Paola ^b   Alisi, Anna ^a   Nobili, Valerio ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b Pediatric Department   (Italy)

Author keywords

Autoimmune hepatitis; Children; HPV vaccination

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN G; PREDNISONE; WART VIRUS VACCINE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; AUTOIMMUNE HEPATITIS TYPE 2; BILIRUBIN BLOOD LEVEL; CANCER IMMUNIZATION; CASE REPORT; CHILD; CORTICOSTEROID THERAPY; FEMALE; GENETIC PREDISPOSITION; HEPATOSPLENOMEGALY; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULIN BLOOD LEVEL; JAUNDICE; LIVER FUNCTION TEST; LIVER NECROSIS; PAPILLOMAVIRUS INFECTION; PATIENT MONITORING; PRIORITY JOURNAL; SCHOOL CHILD; UTERINE CERVIX CANCER;

EID: 79960640292     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.05.002     Document Type: Article

References (19)

1. Chabot I, Goetghebeur MM, Grégoire GP. The social value of universal childhood vaccination. Vaccine 2004;22:1992-2005.
2. Chen RT, Pless R, DeStefano F. Epidemiology of autoimmune reactions induced by vaccination. J Autoimmun 2001;16:309-18.
3. Wraith DC, Goldman M, Lambert PH. Vaccination and autoimmune disease: what is the evidence? Lancet 2003;362:1659-66.
4. Miller E, Waight P, Ferrington CP, Andrews N, Stowe J, Taylor B. Idiopathic thrombocytopenic purpura and MMR vaccine. Arch Dis Child 2001;84:227-9.
5. Kivity S, Agmon-Levin N, Blank M, Shoenfeld Y. Infectious and autoimmunity. Trends Immunol 2009;30:409-14.
6. Shoenfeld Y. Infections, vaccines and autoimmunity. Lupus 2009;18:1127-8.
7. Agmon-Levin N, Paz Z, Israeli E, Shoenfeld Y. Vaccines and autoimmunity. Nat Rev Rheumatol 2009;5:648-52.
8. Isreali E, Agmon-Levin N, Blank M, Shoenfeld Y. Adjuvants and autoimmunity. Lupus 2009;18:1217-25.
9. Mieli-Vergani G, Heller S, Jara P, Vergani D, Chang MH, Fujisawa T, et al. Autoimmune hepatitis. J Pediatr Gastroenterol Nutr 2009;49:158-64.
10. Verstraeten T, Descamps D, David MP, Zahaf T, Hardt K, Izurieta P, et al. Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines. Vaccine 2008;26:6630-8.
11. Stanley M, Lowy DR, Frazer I. Prophylactic HPV vaccines: underlying mechanisms. Vaccine 2006;24(Suppl. 3):106-13.
12. Inglis S, Shaw A, Koenig S. HPV vaccines: commercial research & development. Vaccine 2006;24(Suppl. 3):99-105.
13. Lungarini J, Maddalo F. Results of a vaccination campaign against human papillomavirus in the province of La Spezia, Liguria, Italy, March-December 2008. Euro Surveill 2009;14, pii:19342.
14. Kelly W, Arellano F, Barnes J, Bergman U, Edwards R, Fernandez A, et al. Guidelines for submitting adverse event reports for publication. Therapie 2009;64:289-94.
15. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-38.
16. Berry PA, Smith-Laing G. Hepatitis A vaccine associated with autoimmune hepatitis. World J Gastroenterol 2007;13:2238-9.
17. Balofsky A, Agmon-Levin N, Shoenfeld Y. The new H1N1 and HPV vaccines and old fears. Curr Opin Rheumatol 2010;22:431-6.
18. Orbach H, Agmon-Levin N, Zandman-Goddard G. Vaccines and autoimmune diseases of the adult. Discov Med 2010;9:90-7.
19. Vergani D, Mieli-Vergani G. Mechanisms of autoimmune hepatitis. Pediatr Transplantation 2004;8:589-93.